Educating Scholars of Practice: An Approach to Preparing Tomorrow's Researchers.

Occup Ther Health Care

University of Illinois at Chicago, Department of Occupational Therapy, 1919 W. Taylor Street, MC 811, Chicago, IL, 60612.

Published: August 2013

SUMMARY Occupational therapy's scholarship too often fails to result in a cumulative body of knowledge that is directly relevant to practice, and links theory and research to practice. This problem has its basis in how therapists are prepared to make scholarly contributions to the field. This article describes an educational strategy for preparing scholars of practice whose work will contribute to building a knowledge base that examines and enhances practice. The strategy is based upon social learning theory, employs principles of situated learning and cognitive apprenticeship, and involves students as members of an ongoing community of scholars. Steps to and benefits of creating this scholarly community and implementing this educational strategy are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1080/J003v15n01_15DOI Listing

Publication Analysis

Top Keywords

scholars practice
8
educational strategy
8
practice
5
educating scholars
4
practice approach
4
approach preparing
4
preparing tomorrow's
4
tomorrow's researchers
4
researchers summary
4
summary occupational
4

Similar Publications

The expressway green channel is an essential transportation policy for moving fresh agricultural products in China. In order to extract knowledge from various records, this study presents a cutting-edge approach to extract information from textual records of failure cases in the vertical field of expressway green channel. We proposed a hybrid approach based on BIO labeling, pre-trained model, deep learning and CRF to build a named entity recognition (NER) model with the optimal prediction performance.

View Article and Find Full Text PDF

Biomedical data analytics for better patient outcomes.

Drug Discov Today

December 2024

Hamta Business Corporation, Vancouver, Canada; University Canada West, Vancouver, Canada; Westcliff University, Irvine, USA. Electronic address:

Medical professionals today have access to immense amounts of data, which enables them to make decisions that enhance patient care and treatment efficacy. This innovative strategy can improve global health care by bridging the divide between clinical practice and medical research. This paper reviews biomedical developments aimed at improving patient outcomes by addressing three main questions regarding techniques, data sources and challenges.

View Article and Find Full Text PDF

The early stages of human development are critical for growth, and exposure to arsenic, particularly through the placenta and dietary sources, poses significant health risks. Despite extensive research, significant gaps remain in our comprehension of regional disparities in arsenic exposure and its cumulative impacts during these developmental stages. We hypothesize that infants in certain regions are at greater risk of arsenic exposure and its associated health complications.

View Article and Find Full Text PDF

Background: Adrenocorticotropin (ACTH)-dependent Cushing's syndrome can arise from a pituitary tumour (Cushing's disease) or an ectopic ACTH-secreting tumour, making precise differentiation essential for effective treatment. Bilateral inferior petrosal sinus sampling (BIPSS) is the gold standard for this differentiation, but false-negative results can limit its accuracy. Adding prolactin (PRL) measurement to BIPSS has been proposed to improve diagnostic precision.

View Article and Find Full Text PDF

Addition of Bevacizumab to Chemotherapy and Its Impact on Clinical Efficacy in Cervical Cancer: A Systematic Review and Meta-Analysis.

Pharmacy (Basel)

December 2024

Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Penang, Malaysia.

: Cervical cancer is the third leading cause of cancer-related mortality in females. One of the most successful therapeutic modalities to date is suppressing vascular endothelial growth factor (VEGF)-mediated angiogenesis. Bevacizumab is a monoclonal antibody that targets VEGF-A.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!